Yoshimi Oda

798 total citations
26 papers, 694 citations indexed

About

Yoshimi Oda is a scholar working on Molecular Biology, Plant Science and Complementary and alternative medicine. According to data from OpenAlex, Yoshimi Oda has authored 26 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Plant Science and 7 papers in Complementary and alternative medicine. Recurrent topics in Yoshimi Oda's work include Bioactive Compounds and Antitumor Agents (5 papers), melanin and skin pigmentation (4 papers) and Natural product bioactivities and synthesis (4 papers). Yoshimi Oda is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), melanin and skin pigmentation (4 papers) and Natural product bioactivities and synthesis (4 papers). Yoshimi Oda collaborates with scholars based in Japan, United States and China. Yoshimi Oda's co-authors include Seikou Nakamura, Hisashi Matsuda, Souichi Nakashima, Masayuki Yoshikawa, Jung San Huang, M D Kuo, Shuan Shian Huang, Fengming Xu, Takahiro Μatsumoto and Tomoe Ohta and has published in prestigious journals such as Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Yoshimi Oda

25 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshimi Oda Japan 15 336 163 132 97 89 26 694
Zhenzhong Yang China 13 284 0.8× 90 0.6× 63 0.5× 97 1.0× 106 1.2× 38 599
Jin‐Gyeong Cho South Korea 18 400 1.2× 239 1.5× 81 0.6× 146 1.5× 78 0.9× 53 768
Yuanye Dang China 18 724 2.2× 146 0.9× 61 0.5× 51 0.5× 192 2.2× 30 1.2k
D. Paper Germany 17 349 1.0× 268 1.6× 55 0.4× 64 0.7× 50 0.6× 24 884
Horng‐Huey Ko Taiwan 13 336 1.0× 77 0.5× 149 1.1× 119 1.2× 28 0.3× 19 568
Yeong‐Geun Lee South Korea 18 427 1.3× 190 1.2× 50 0.4× 110 1.1× 123 1.4× 79 855
Soo‐Jin Choo South Korea 15 259 0.8× 123 0.8× 128 1.0× 62 0.6× 45 0.5× 25 559
Xuefeng Huang China 21 698 2.1× 264 1.6× 29 0.2× 57 0.6× 124 1.4× 47 1.0k
An-Cheng Huang Taiwan 17 557 1.7× 143 0.9× 43 0.3× 56 0.6× 66 0.7× 20 901
Kader Turkekul Türkiye 12 359 1.1× 65 0.4× 40 0.3× 72 0.7× 60 0.7× 15 691

Countries citing papers authored by Yoshimi Oda

Since Specialization
Citations

This map shows the geographic impact of Yoshimi Oda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Oda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Oda more than expected).

Fields of papers citing papers by Yoshimi Oda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Oda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Oda. The network helps show where Yoshimi Oda may publish in the future.

Co-authorship network of co-authors of Yoshimi Oda

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshimi Oda. A scholar is included among the top collaborators of Yoshimi Oda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshimi Oda. Yoshimi Oda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nakashima, Souichi, Yoshimi Oda, Kaneyasu Nishimura, et al.. (2023). Plantainoside B in <i>Bacopa monniera</i> Binds to Aβ Aggregates Attenuating Neuronal Damage and Memory Deficits Induced by Aβ. Biological and Pharmaceutical Bulletin. 46(2). 320–333. 1 indexed citations
3.
Nakashima, Souichi, et al.. (2022). Analysis of Active Compounds Using Target Protein Cofilin―Cucurbitacins in Cytotoxic Plant Bryonia cretica. Toxins. 14(3). 212–212. 2 indexed citations
4.
Nakashima, Souichi, Seikou Nakamura, Kaneyasu Nishimura, et al.. (2020). Accelerative effects of carbazole-type alkaloids from Murraya koenigii on neurite outgrowth and their derivative’s in vivo study for spatial memory. Journal of Natural Medicines. 74(2). 448–455. 9 indexed citations
5.
Nakashima, Souichi, et al.. (2019). BBB-permeable aporphine-type alkaloids in Nelumbo nucifera flowers with accelerative effects on neurite outgrowth in PC-12 cells. Journal of Natural Medicines. 74(1). 212–218. 17 indexed citations
6.
Wang, Weicheng, Souichi Nakashima, Seikou Nakamura, Yoshimi Oda, & Hisashi Matsuda. (2019). Anti-proliferative effect of auriculataoside A on B16 melanoma 4A5 cells by suppression of Cdc42–Rac1–RhoA signaling protein levels. Journal of Natural Medicines. 73(3). 450–455. 3 indexed citations
7.
Oda, Yoshimi, et al.. (2018). Comparison of lawsone contents among Lawsonia inermis plant parts and neurite outgrowth accelerators from branches. Journal of Natural Medicines. 72(4). 890–896. 23 indexed citations
8.
Nakashima, Souichi, Yoshimi Oda, Yuki Ogawa, et al.. (2018). Protective Effects of Compounds in Bombax ceiba flower on Benzo[a]pyrene-Induced Cytotoxicity. Natural Product Communications. 13(5). 1 indexed citations
9.
Ohta, Tomoe, Seikou Nakamura, Souichi Nakashima, et al.. (2017). Stimulators of acylated ghrelin secretion from Moringa oleifera leaves. Phytochemistry Letters. 21. 1–5. 7 indexed citations
10.
Ohta, Tomoe, Seikou Nakamura, Souichi Nakashima, et al.. (2016). Chemical structures of constituents from the whole plant of Bacopa monniera. Journal of Natural Medicines. 70(3). 404–411. 17 indexed citations
11.
Oda, Yoshimi, et al.. (2016). New potent accelerator of neurite outgrowth from Lawsonia inermis flower under non-fasting condition. Journal of Natural Medicines. 70(3). 384–390. 10 indexed citations
12.
Nakamura, Seikou, Yi Zhang, Souichi Nakashima, et al.. (2016). Structures of Aromatic Glycosides from the Seeds of <i>Cassia auriculata</i>. Chemical and Pharmaceutical Bulletin. 64(7). 970–974. 9 indexed citations
13.
Nakashima, Souichi, Yoshimi Oda, Seikou Nakamura, et al.. (2015). Inhibitors of melanogenesis in B16 melanoma 4A5 cells from flower buds of Lawsonia inermis (Henna). Bioorganic & Medicinal Chemistry Letters. 25(13). 2702–2706. 21 indexed citations
14.
Nakamura, Seikou, Fengming Xu, Kiyofumi Ninomiya, et al.. (2014). Chemical Structures and Hepatoprotective Effects of Constituents from <i>Cassia auriculata</i> Leaves. Chemical and Pharmaceutical Bulletin. 62(10). 1026–1031. 23 indexed citations
15.
Nakamura, Seikou, Souichi Nakashima, Yoshimi Oda, et al.. (2013). Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: Structures of karapinchamines A and B. Bioorganic & Medicinal Chemistry. 21(5). 1043–1049. 49 indexed citations
16.
Nakamura, Seikou, Souichi Nakashima, Yoshimi Oda, et al.. (2012). Alkaloid constituents from flower buds and leaves of sacred lotus (Nelumbo nucifera, Nymphaeaceae) with melanogenesis inhibitory activity in B16 melanoma cells. Bioorganic & Medicinal Chemistry. 21(3). 779–787. 81 indexed citations
17.
Nakashima, Souichi, Hisashi Matsuda, Yoshimi Oda, et al.. (2010). Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells. Bioorganic & Medicinal Chemistry. 18(6). 2337–2345. 78 indexed citations
18.
Nakashima, Souichi, Hisashi Matsuda, Yoshimi Oda, et al.. (2010). Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. Bioorganic & Medicinal Chemistry Letters. 20(9). 2994–2997. 54 indexed citations
19.
20.
Sugimoto, Sachiko, et al.. (2009). Brazilian Natural Medicines. III. Structures of Triterpene Oligoglycosides and Lipase Inhibitors from Mate, Leaves of Ilex paraguariensis. Chemical and Pharmaceutical Bulletin. 57(3). 257–261. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026